Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Proteostasis Therapeutics, Inc.

NASDAQ: PTITechnology / Application Software / India
4.07-0.0700-1.69%Vol 721 2751Y Perf 30.87%
Feb 15th, 2019 16:00
BID4.02 ASK4.24
Open4.16 Previous Close4.14
Pre-Market4.12 After-Trading4.07
 -0.02 -0.48%  - -%
Target Price
14.00 
Analyst Rating
Strong Buy 1.25
Potencial %
243.98 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-71/-71 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/31/31 
Growth Ranking
★+     39.19
Insiders Shares Cnt. % 3/6/12M
-100/-8/-8 
Income Ranking
 —    -
Market Cap (mil)149 
Earnings Rating
Sell
Price Range Ratio 52wk %
27.22 
Earnings Date
13th Mar 2019

Today's Price Range

3.984.25

 

52wk Range

1.7110.38

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
28.39%
3 Months
-33.71%
6 Months
74.68%
1 Year
30.87%
3 Years
-29.22%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
PTI4.07-0.0700-1.69
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
4.00
Current Ratio
4.20
Long Term Debt to Total Capital
0.26
Total Debt to Equity
0.37
Interest Coverage
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 326.60
EBITDA Margin
-1 311.80
Pre-tax Profit Margin
-711.30
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
4.19
PS Ratios
57.43
Price to Cash Flow
-
Price to Free Cash Flow
-4.10
Cash Flow Per Share
-1.54
Price to Tangible Book
4.19
Book Value per Share
0.77
Enterprise Value (in ths.)
131 193
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
127.35
ROE last 12 Months
-151.13
Return on Assets (5Y Avg)
-51.77
ROA last 12 Months
-93.61
Return on Capital (5Y Avg)
-
ROC last 12 Months
-111.10
Return on invested Capital Q
-29.88
Return on invested Capital Y
-80.00
Assets Turnover
0.00
Receivables Turnover
2.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 840
Revenue per Share
0.06
Revenue Growth 3 Years
-9.18
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.46-0.50-8.70
Q02 2018-0.41-0.43-4.88
Q01 2018-0.51-0.3237.25
Q04 2017-0.65-0.5121.54
Q03 2017-0.63-0.5611.11
Q02 2017-0.61-0.68-11.48
Q01 2017-0.58-0.60-3.45
Q04 2016-0.51-0.3825.49
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.460.00-
12/2018 FY-1.687.69Positive
3/2019 QR-0.500.00-
12/2019 FY-2.10-0.96Negative
Next Report Date13th Mar 2019
Estimated EPS Next Report-0.46
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume721 275
Shares Outstanding (in ths.)36 697
Trades Count2 242
Dollar Volume2 637 589
Avg. Volume1 134 151
Avg. Weekly Volume2 863 549
Avg. Monthly Volume1 355 812
Avg. Quarterly Volume1 071 234

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.25
Strong Buy
1.25

There are no comments yet.

News